Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PILOT: Prevnar Long-term Immune Response
NCT00824850Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Prevnar 13 in pneumococcal infection, sponsored by Pfizer. Started Jan 2010; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00824850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824850.